Children’s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina, Kyle S. Smith, Catherine A. Billups, Peter C. Burger, Leanne M. Embry, Patricia L. Cullen, Kristina K. Hardy, Scott L. Pomeroy, Johnnie K. Bass, Stephanie M. Perkins, Thomas E. Merchant, Paul D. Colte, Thomas J. Fitzgerald, Timothy N. Booth, Joel M. Cherlow, Karin M. Muraszko, Jennifer Hadley, Rahul KumarYuanyuan Han, Nancy J. Tarbell, Maryam Fouladi, Ian F. Pollack, Roger J. Packer, Yimei Li, Amar Gajjar, Paul A. Northcott

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Children’s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences